From the Journals

Rising arthritis prevalence driven by obesity


 

FROM ARTHRITIS CARE & RESEARCH

Rising obesity is driving an increase in arthritis prevalence, and the association is not appreciated because the impact of body mass index on joint disease is not fully understood, according to a study spanning four generations.

The proportion of people in more recent birth cohorts reporting arthritis symptoms indicates a successively greater prevalence of arthritis compared to earlier generations, based on an 18-year longitudinal study conducted by Elizabeth M. Badley, PhD, of Dalla Lana School of Public Health, University of Toronto, and her colleagues. The researchers compared the prevalence of arthritis across four birth cohorts: World War II (1935-1944; n = 1,598), older baby boomers (1945-1954; n = 2,208), younger baby boomers (1955-1964; n = 2,781) and Generation Xers (1965-1974; n = 2,230).

“Although our results do not represent projections as such, extrapolation of the trajectories of arthritis with age and comparison of the trajectories across cohorts suggest that current projections of the prevalence of arthritis … may be too low for obese individuals,” they concluded.

Using the World War II cohort as the reference group for comparison, the odds ratio for arthritis in Gen Xers was 3.2; for younger baby boomers it was 2.14; for older baby boomers, it was 1.48.

SandraMatic/Thinkstock
Within the youngest cohort, the higher arthritis prevalence was magnified. The most obese patients in this cohort were 2.5 times more likely to report arthritis, compared with those of normal weight.

Furthermore, in all cohorts the age of onset of arthritis in obese individuals was earlier compared to those of normal weight.

“This has implications for the targeting of public health messages for the control and management of arthritis,” the researchers wrote (Arthritis Care Res. 2017. doi: 10.1002/acr.23213).

The authors noted that although the study participants were asked about arthritis in general it was likely the overall findings reflected an increasing prevalence of osteoarthritis.

And while the researchers could only speculate about the reasons for the higher prevalence of arthritis seen in recent cohorts, it was possible there had been “unrecognized changes over time in environmental or biologic exposures.”

The study was funded in part by a CIHR operating grant. No conflicts of interest were declared.

Recommended Reading

Beta-blockers reduce pain, opioid use in osteoarthritis
MDedge Internal Medicine
Anti–nerve growth factor drug has long-term OA pain benefit, but unclear safety
MDedge Internal Medicine
OA progresses equally with new focal partial- or full-thickness cartilage damage
MDedge Internal Medicine
VIDEO: PRECISION exonerates celecoxib: cardiovascular risk is no worse than that of nonselective NSAIDs
MDedge Internal Medicine
VIDEO: Celecoxib just as safe as naproxen or ibuprofen in OA and RA
MDedge Internal Medicine
Fiber may play role in lessening knee pain, OA development
MDedge Internal Medicine
OA drug development needs patient-focused approach to biomarkers and outcome measures
MDedge Internal Medicine
Thigh muscle weakness predicts knee osteoarthritis in women only
MDedge Internal Medicine
Osteoarthritis in hip or knee can increase diabetes risk
MDedge Internal Medicine
CDC: Greater activity limitations accompany rising arthritis prevalence
MDedge Internal Medicine